Orthofix Medical Inc. (NASDAQ:OFIX) Given Average Rating of “Hold” by Analysts

Orthofix Medical Inc. (NASDAQ:OFIX) has been given an average rating of “Hold” by the five analysts that are covering the stock, MarketBeat reports. Three research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $18.00.

Several equities analysts recently commented on the stock. Roth Mkm upgraded shares of Orthofix Medical from a “neutral” rating to a “buy” rating and upped their price target for the company from $15.00 to $20.00 in a research note on Wednesday, May 8th. JMP Securities restated a “market perform” rating on shares of Orthofix Medical in a research note on Monday, April 22nd. StockNews.com upgraded shares of Orthofix Medical from a “sell” rating to a “hold” rating in a research note on Wednesday, May 8th. Finally, Roth Capital upgraded shares of Orthofix Medical from a “neutral” rating to a “buy” rating in a research note on Wednesday, May 8th.

Institutional Investors Weigh In On Orthofix Medical

Institutional investors and hedge funds have recently bought and sold shares of the company. GSA Capital Partners LLP bought a new stake in Orthofix Medical during the first quarter worth about $921,000. Engine Capital Management LP bought a new stake in Orthofix Medical during the fourth quarter worth about $40,916,000. Jump Financial LLC bought a new stake in Orthofix Medical during the fourth quarter worth about $1,445,000. Boone Capital Management LLC bought a new stake in Orthofix Medical during the fourth quarter worth about $6,740,000. Finally, Charles Schwab Investment Management Inc. lifted its position in Orthofix Medical by 7.5% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 461,885 shares of the medical device company’s stock worth $6,226,000 after purchasing an additional 32,400 shares during the period. Institutional investors own 89.76% of the company’s stock.

Orthofix Medical Price Performance

NASDAQ:OFIX opened at $16.51 on Tuesday. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.65 and a quick ratio of 1.19. The firm’s fifty day moving average price is $14.20 and its two-hundred day moving average price is $13.99. Orthofix Medical has a one year low of $9.57 and a one year high of $21.60. The company has a market cap of $619.62 million, a P/E ratio of -4.88 and a beta of 1.05.

Orthofix Medical (NASDAQ:OFIX) last released its quarterly earnings results on Tuesday, May 7th. The medical device company reported ($0.95) EPS for the quarter, missing the consensus estimate of ($0.54) by ($0.41). Orthofix Medical had a negative net margin of 16.64% and a negative return on equity of 14.24%. The business had revenue of $188.61 million during the quarter, compared to analyst estimates of $183.40 million. Equities analysts expect that Orthofix Medical will post -1.72 earnings per share for the current year.

About Orthofix Medical

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.